Document Detail

Blood pressure levels and bleeding events during antithrombotic therapy: the Bleeding with Antithrombotic Therapy (BAT) Study.
MedLine Citation:
PMID:  20489173     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: A prospective, multicenter, observational cohort study was conducted to clarify the association between major bleeding events and blood pressure (BP) levels during follow-up before development of bleeding events in antithrombotic users.
METHODS: A total of 4009 patients taking oral antithrombotic agents for cardiovascular or cerebrovascular diseases (2728 men, 69+/-10 years old) were followed. Changes in systolic and diastolic BPs between entry and the last clinic visit before intracranial hemorrhage (ICH) or extracranial hemorrhage were assessed.
RESULTS: Over a median follow-up of 19 months, ICH developed in 31 patients and extracranial hemorrhage developed in 77. Entry BP levels were similar among patients with ICH, those with extracranial hemorrhage, and those without hemorrhagic events. Both systolic BP and diastolic BP were relatively high during follow-up as compared with the levels at entry in patients with ICH, whereas they showed plateaus in patients with extracranial hemorrhage and patients without hemorrhagic events. Average systolic BP levels between 1 and 6 months (hazard ratio, 1.45; 95% CI, 1.08 to 1.92 per 10-mm Hg increase) and between 7 and 12 months (hazard ratio, 1.47; 95% CI, 1.05 to 2.01) as well as average diastolic BP levels between 7 and 12 months (hazard ratio, 2.05; 95% CI, 1.15 to 3.62) were independently associated with development of ICH after adjustment for established ICH predictors. The optimal cutoff BP level to predict impending risk of ICH was >or=130/81 mm Hg using receiver operating characteristic curve analysis.
CONCLUSIONS: An increase in BP levels during antithrombotic medication was positively associated with development of ICH, suggesting the importance of adequate BP control for avoiding ICH. BP levels did not appear to be associated with extracranial hemorrhage.
Kazunori Toyoda; Masahiro Yasaka; Shinichiro Uchiyama; Takehiko Nagao; Jun Gotoh; Ken Nagata; Yukihiro Koretsune; Tomohiro Sakamoto; Kazunori Iwade; Masahiro Yamamoto; Jun C Takahashi; Kazuo Minematsu;
Related Documents :
19951053 - Stereotactic spine radiosurgery for intradural and intramedullary metastasis.
3655833 - Do cerebral arteriovenous malformations increase in size?
3499323 - Retrospective evaluation of single photon emission computed tomography of the liver.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2010-05-20
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  41     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-29     Completed Date:  2010-07-20     Revised Date:  2010-12-10    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1440-4     Citation Subset:  IM    
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Blood Pressure / drug effects*,  physiology*
Cohort Studies
Fibrinolytic Agents / adverse effects*
Follow-Up Studies
Hemorrhage / chemically induced*,  epidemiology*
Middle Aged
Prospective Studies
Reg. No./Substance:
0/Fibrinolytic Agents
K Minematsu / ; K Toyoda / ; A Tokunaga / ; A Takebayashi / ; M Yasaka / ; S Uchiyama / ; M Yamamoto / ; T Nagao / ; T Sakamoto / ; M Yasaka / ; K Iwade / ; K Nagata / ; J Gotoh / ; Y Koretsune / ; K Minematsu / ; J Takahashi / ; T Ochi / ; T Umemoto / ; T Nakazato / ; M Shimizu / ; M Okamoto / ; H Shinohara / ; T Takemura / ; M Jougasaki / ; H Matsuoka /
Comment In:
Evid Based Med. 2010 Dec;15(6):189-90   [PMID:  20797990 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lifetime Risk of Stroke in Japan.
Next Document:  Development of Stroke Performance Measures. Definitions, Methods, and Current Measures.